Methyl 8-Bromo-6-methylimidazo[1,2-a]pyridine-2-carboxylate

Catalog No.: 
ACHLTY168
CAS No.: 
1171424-92-2
Molecular Formula: 
C10H9BrN2O2
Molecular Weight: 
269.10
Methyl 8-Bromo-6-methylimidazo[1,2-a]pyridine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$157.00InquiryInquiry
1g97%$264.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 8-Bromo-6-methylimidazo[1,2-a]pyridine-2-carboxylate
IUPAC Namemethyl 8-bromo-6-methylimidazo[1,2-a]pyridine-2-carboxylate
MDL No.MFCD12026326
Molecular FormulaC10H9BrN2O2
Molecular Weight269.10
SMILESO=C(C1=CN2C=C(C)C=C(Br)C2=N1)OC
InChI KeyPEFZRFNEABRZOX-UHFFFAOYSA-N
SynonymMethyl 8-BroMo-6-MethyliMidazo[1,2-a]pyridin-2-carboxylate;Methyl 8-Bromo-6-methylimidazo[1,2-a]pyridine-2-carboxylate;Imidazo[1,2-a]pyridine-2-carboxylic acid, 8-bromo-6-methyl-, methyl ester
CAS No.1171424-92-2

Synthetic Route by SureRoute

1. ACHLTY168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWDA697 route compound structure diagram
    ACCWDA69713061-96-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHLTY168 route product structure diagram
    ACHLTY1681171424-92-2
Inquiry

2. ACHLTY168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHLTY168 route product structure diagram
    ACHLTY1681171424-92-2
Inquiry

3. ACHLTY168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHLTY168 route product structure diagram
    ACHLTY1681171424-92-2
Inquiry

Comments (0)